US population qualifying for aspirin use for primary prevention of cardiovascular disease

• Main Authors: Athena L. Huang (Author), Ann Marie Navar (Author), Colby Ayers (Author), Anand Rohatgi (Author), Erin D. Michos (Author), Salim S. Virani (Author), Parag Joshi (Author), Eric D. Peterson (Author), Amit Khera (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Aspirin has been used for primary prevention of atherosclerotic cardiovascular disease (ASCVD) for decades, but this indication has become controversial with recent trial data. The 2022 US Preventive Services Task Force (USPSTF) provided a recommendation to consider aspirin use for primar...